These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 5509064)
1. [Clinical experiences with heparmez]. Baumann M Z Allgemeinmed; 1970 Jun; 46(17):895-900. PubMed ID: 5509064 [No Abstract] [Full Text] [Related]
2. [Experiences with ornithine-aspartate in liver diseases]. Aschke J Med Welt; 1969 Mar; 12():657-62. PubMed ID: 5767441 [No Abstract] [Full Text] [Related]
3. [Further clinical experiences with ornithine aspartate in liver diseases]. Wotzka R; Weber D Ther Ggw; 1972 Mar; 111(3):400-12. PubMed ID: 5024593 [No Abstract] [Full Text] [Related]
4. [Study of the treatment of liver damage due to several causes in tuberculosis, using ornithine-aspartate]. Seki S Iryo; 1966 Apr; 20(4):354-63. PubMed ID: 5974194 [No Abstract] [Full Text] [Related]
5. [Personal experiences in the treatment of internal diseases with ornithine aspartate]. Perinović M; Robović Z; Grujić M; Ljubojević S Med Arh; 1969; 23(3):29-32. PubMed ID: 5200044 [No Abstract] [Full Text] [Related]
6. [Clinical study on the effects of L-ornithine-L-aspartate on liver dysfunction]. Kosozu K Iryo; 1966 Apr; 20(4):339-46. PubMed ID: 5974192 [No Abstract] [Full Text] [Related]
7. [On prednisolone therapy of epidemic hepatitis with several concomitant diseases]. Latenko IaP; Ziva VK; Kostiuk LK Sov Med; 1967 Aug; 30(8):76-8. PubMed ID: 5304938 [No Abstract] [Full Text] [Related]
8. [Clinical experiences in liver diseases (specially in patients with fatty liver due to alcoholism and food poisoning) under monotherapy with ornithine aspartate]. Hunold W Z Allgemeinmed; 1973 Apr; 49(10):469-72. PubMed ID: 4580434 [No Abstract] [Full Text] [Related]
9. [Infectius hepatitis (Botkin's disease) in patients with pulmonary tuberculosis]. Bugakova GN Probl Tuberk; 1970; 48(8):44-7. PubMed ID: 5531579 [No Abstract] [Full Text] [Related]
10. [Clinical trial of alpha ornithine ketoglutarate]. Linquette M; Fossati P; Hubschman B Lille Med; 1969 Apr; 14():Suppl 3:512-5. PubMed ID: 5376446 [No Abstract] [Full Text] [Related]
12. [The therapy of states of exhaustion with Ornithin-Aspartat]. Simon KH Med Monatsschr; 1968 Jan; 22(1):30-1. PubMed ID: 5707445 [No Abstract] [Full Text] [Related]
13. [Influence of ornithine aspartate on the experimentally induced hyperammoniemia. Clinico-experimental study]. Henglein-Ottermann D Ther Ggw; 1976 Sep; 115(9):1504-18. PubMed ID: 968783 [No Abstract] [Full Text] [Related]
15. [Course of viral hepatitis in subjects with pulmonary tuberculosis]. Arcuri F; Piersantelli N; Rizzo F Arch Maragliano Patol Clin; 1968; 24(6):699-707. PubMed ID: 5757339 [No Abstract] [Full Text] [Related]
16. [Protection of the liver and liver therapy with Hepamerz]. Heynen U Z Allgemeinmed; 1970 Jan; 46(2):87-8. PubMed ID: 5439291 [No Abstract] [Full Text] [Related]
18. [On some peculiarities of the course of pulmonary tuberculosis in patients with infectious hepatitis]. Pak FP Probl Tuberk; 1966; 44(9):32-6. PubMed ID: 5994510 [No Abstract] [Full Text] [Related]
19. [Course of infectious hepatitis in patients with pulmonary tuberculosis]. Kolotovkin PS Ter Arkh; 1970 Feb; 42(2):30-3. PubMed ID: 5446859 [No Abstract] [Full Text] [Related]
20. [Viral hepatitis in patients with pulmonary tuberculosis]. Graczyk J; Zachara A Gruzlica; 1968 Feb; 36(2):145-50. PubMed ID: 5665503 [No Abstract] [Full Text] [Related] [Next] [New Search]